Literature DB >> 30548724

What's new in the treatment of atopic dermatitis?

Annunziata Dattola1, Luigi Bennardo2, Martina Silvestri2, Steven Paul Nisticò2.   

Abstract

Atopic dermatitis (AD) is a pruritic, chronic and inflammatory skin disease, with an usual onset in the pediatric age. Several drugs are used in the treatment of this skin disease. Drugs as steroid, calcineurin inhibitors, and moisturizing creams are widely used in the treatment of this disease but often patients are not satisfied with the obtained results. New drugs like dupilumab or crisaborole seem to be a promising option for moderate and severe forms of AD. This article analyzes the newest therapy available today for the treatment of AD.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  atopic dermatitis; new drugs

Mesh：

Substances：

Year:  2018        PMID： 30548724     DOI： 10.1111/dth.12787

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


  25 in total

Review 1.  Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis: Focus on Abrocitinib, Baricitinib, and Upadacitinib.

Authors:  Miguel Nogueira; Tiago Torres
Journal:  Dermatol Pract Concept       Date:  2021-10-01

2.  Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey.

Authors:  Joaquín Sastre; Esther Serra Baldrich; José Carlos Armario Hita; L Herráez; Ignacio Jáuregui; Ana Martín-Santiago; Javier Ortiz de Frutos; Juan Francisco Silvestre; Antonio Valero
Journal:  Dermatol Res Pract       Date:  2020-04-07

Review 3.  Intractable Itch in Atopic Dermatitis: Causes and Treatments.

Authors:  Yoshie Umehara; Chanisa Kiatsurayanon; Juan Valentin Trujillo-Paez; Panjit Chieosilapatham; Ge Peng; Hainan Yue; Hai Le Thanh Nguyen; Pu Song; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Biomedicines       Date:  2021-02-25

4.  Derma-Hc, a New Developed Herbal Formula, Ameliorates Cutaneous Lichenification in Atopic Dermatitis.

Authors:  Yeon Kyung Nam; Mi Hye Kim; In Jin Ha; Woong Mo Yang
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

5.  Anti-Inflammatory Effects of Ellagic Acid on Keratinocytes via MAPK and STAT Pathways.

Authors:  Tae-Young Gil; Chul-Hee Hong; Hyo-Jin An
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

Review 6.  Selective IL-13 inhibitors for the treatment of atopic dermatitis.

Authors:  Francisca Gonçalves; Egídio Freitas; Tiago Torres
Journal:  Drugs Context       Date:  2021-03-30

7.  Use of Systemic Medications for Treating Adult Atopic Dermatitis in France: Results of a Practice Survey.

Authors:  Anne-Claire Fougerousse; Caroline Jacobzone; Laure Mery-Bossard; Ziad Reguiai; Catherine Droitcourt; Charles Taieb; François Maccari
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-02-25

8.  The Effectiveness of Probiotic Lactobacillus rhamnosus and Lactobacillus casei Strains in Children with Atopic Dermatitis and Cow's Milk Protein Allergy: A Multicenter, Randomized, Double Blind, Placebo Controlled Study.

Authors:  Bożena Cukrowska; Aldona Ceregra; Elżbieta Maciorkowska; Barbara Surowska; Maria Agnieszka Zegadło-Mylik; Ewa Konopka; Ilona Trojanowska; Magdalena Zakrzewska; Joanna Beata Bierła; Mateusz Zakrzewski; Ewelina Kanarek; Ilona Motyl
Journal:  Nutrients       Date:  2021-04-01       Impact factor: 5.717

Review 9.  Cutting Edge of the Pathogenesis of Atopic Dermatitis: Sphingomyelin Deacylase, the Enzyme Involved in Its Ceramide Deficiency, Plays a Pivotal Role.

Authors:  Genji Imokawa
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

10.  The Effect of SARS-CoV-2 Virus Infection on the Course of Atopic Dermatitis in Patients.

Authors:  Martyna Miodońska; Agnieszka Bogacz; Magdalena Mróz; Szymon Mućka; Andrzej Bożek
Journal:  Medicina (Kaunas)       Date:  2021-05-22       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.